Gary Peter Tomkinson

This inventor holds 6 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Astrazeneca Ab. Active years: 2010-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary Peter Tomkinson. Retrieved from https://idiyas.com/inventor/gary-peter-tomkinson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 5)

% Patents Active = 50.0

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 10(Granted Patents)

Location History:

Cheshire, GB (2015)
Macclesfield, GB (2010 - 2018)

Company Filing History:

6 out of 1,534

Astrazeneca Ab

patents

Years Active: 2010-2018

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10039766 - Crystalline forms of (s)-4-amino-n-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7h-pyrrolo[2,3-d] pyrimidin-4-y1) piperidine-4-carboxamide (2018-08-07),

2. 9657008 - Chemical compounds (2017-05-23),

3. 9487525 - Crystalline forms of (s)-4-amino-n-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7h-pyrrolo[2,3-d]pyrimidin-4-yl) piperidine-4-carboxamide (2016-11-08),

4. 9156831 - Chemical compounds (2015-10-13),

5. 7951833 - Crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]Benzoic acid 471 (2011-05-31),

6. 7696191 - Crystalline compound (2010-04-13),

Title: Gary Peter Tomkinson: Innovator in Pharmaceutical Chemistry

Introduction

Gary Peter Tomkinson is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of six patents. His work primarily focuses on the development of new chemical compounds and their applications in therapy.

Latest Patents

Among his latest patents is the invention concerning crystalline forms of (S)-4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide. This invention discloses new solid-state forms of the compound, processes for preparing these forms, pharmaceutical compositions that include them, and their therapeutic uses. Another significant patent involves chemical compounds of Formula (I) or pharmaceutically acceptable salts thereof, which are aimed at treating cell proliferative disorders.

Career Highlights

Gary Peter Tomkinson is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to innovative solutions in the pharmaceutical industry.

Collaborations

He has collaborated with notable colleagues such as Benedicte Delouvrie and Craig Steven Harris, enhancing the research and development efforts within his field.

Conclusion

Gary Peter Tomkinson's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of therapeutic solutions in medicine.

Profile summary based on public USPTO records.